Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 11,040 | 9,520 | 8,050 | 4,920 | 2,820 |
| Cost of Goods | 3,290 | 4,570 | 3,270 | 1,250 | 200 |
| Gross Profit | 7,740 | 4,940 | 4,780 | 3,660 | 2,620 |
| Operating Expenses | 15,030 | 14,800 | 13,690 | 12,810 | 9,530 |
| Operating Income | -6,990 | -9,280 | -8,640 | -8,890 | -6,710 |
| Interest Expense | 70 | 0 | 0 | 0 | 0 |
| Other Income | 250 | 230 | 430 | 560 | -110 |
| Pre-tax Income | -6,810 | -9,050 | -8,210 | -8,330 | -6,820 |
| Income Tax | 10 | -1,240 | -1,370 | -1,480 | -70 |
| Net Income Continuous | -6,694 | -7,812 | -6,841 | -6,851 | -6,751 |
| Net Income | $-6,690 | $-7,810 | $-6,840 | $-6,850 | $-6,750 |
| EPS Basic Total Ops | -0.52 | -0.65 | -0.65 | -0.80 | -1.08 |
| EPS Basic Continuous Ops | -0.52 | -0.65 | -0.65 | -0.80 | -1.08 |
| EPS Diluted Total Ops | -0.52 | -0.65 | -0.65 | -0.80 | -1.08 |
| EPS Diluted Continuous Ops | -0.52 | -0.65 | -0.65 | -0.80 | -1.08 |
| EBITDA(a) | $-6,990 | $-9,280 | $-8,640 | $-8,890 | $-6,710 |